Table 3. Biochemical profiles.
Variables | Without OSA | With OSA | P value |
---|---|---|---|
(n = 57) | (n = 190) | ||
Lipid Profile (mg/dl) | |||
Fasting blood glucose | 93.7.69 ± 20.68 | 92.17 ± 23.35 | 0.3 |
Total cholesterol | 160.23 ± 35.39 | 151.68 ± 26.83 | 0.34 |
Serum triglycerides | 175.55 ± 125.09 | 106.13 ± 54.87 | 0.231 |
HDL-C | 45.6 ± 1.97 | 35.87 ± 6.85 | 0.092 |
VLDL-C | 35.21 ± 25.15 | 22.63 ± 11.37 | 0.284 |
Insulin markers | |||
Fating insulin (μU/ml) | 8.2±3.2 | 10.4±2.3 | 0.03 |
HOMA-IR | 1.7±0.8 | 2.8±0.98 | 0.04 |
Liver enzymes (IU) | |||
ALT | 26.58 ± 17.35 | 39.41 ± 34.39 | 0.003 |
AST | 27.5 ± 12.68 | 33.20 ± 16.70 | 0.09 |
ALP | 496.51 ± 204.34 | 589.59 ± 247.98 | 0.04 |
Other investigations | |||
Albumin (gm %) | 4.74 ± 0.33 | 4.77 ± 0.45 | 0.792 |
Bilirubin conjugated (mg %) | 0.5666 ± 1.12 | 0.33333 ± .24 | 0.715 |
Total Protein (gm %) | 7.1063 ± 0.92 | 7.3464 ± 7.24 | 0.184 |
Potassium (mEq/L) | 135.85 ± 23.74 | 109.96 ± 56.86 | 0.026 |
Creatinine (mg %) | 0.52978 ± 0.12 | 0.45161 ± 0.95 | 0.004 |
Urea (mg %) | 26.92 ± 22.59 | 21.59 ± 5.88 | 0.21 |
All values are given as mean± standard deviation; n, number of subjects. HDL-C, high-density lipoprotein cholesterol; VLDL, very low-density lipoprotein; alanine transaminase, ALT; aspartate aminotransferase, AST, alkaline phosphate ALP, HOMA-IR, homoeostasis modal assessment for insulin resistance.